For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Summit Therapeutics Inc (NASDAQ: SMMT) closed at $5.31 in the last session, up 18.79% from day before closing price of $4.47. In other words, the price has increased by $18.79 from its previous closing price. On the day, 4.79 million shares were traded. SMMT stock price reached its highest trading level at $5.35 during the session, while it also had its lowest trading level at $4.5.
Ratios:
We take a closer look at SMMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.97 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 2.48 whereas as Long-Term Debt/Eq ratio is at 2.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on May-08-24, initiated with a Buy rating and assigned the stock a target price of $7.
On March 26, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 26,000 shares of SMMT for $96,720 on Mar 27 ’24. The Chief Executive Officer now owns 520,814 shares after completing the transaction at $3.72 per share. On Mar 26 ’24, another insider, Dhingra Ankur, who serves as the Chief Financial Officer of the company, bought 100,000 shares for $3.75 each. As a result, the insider paid 375,000 and bolstered with 354,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 3727513856 and an Enterprise Value of 3680353536.
Stock Price History:
Over the past 52 weeks, SMMT has reached a high of $5.22, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is 31.22%, while the 200-Day Moving Average is calculated to be 88.25%.
Shares Statistics:
According to the various share statistics, SMMT traded on average about 2.23M shares per day over the past 3-months and 2088540 shares per day over the past 10 days. A total of 701.66M shares are outstanding, with a floating share count of 83.02M. Insiders hold about 88.17% of the company’s shares, while institutions hold 4.65% stake in the company. Shares short for SMMT as of 1713139200 were 22896771 with a Short Ratio of 10.26, compared to 1710460800 on 16964061. Therefore, it implies a Short% of Shares Outstanding of 22896771 and a Short% of Float of 27.41.
